» Articles » PMID: 20110184

Circulating Levels of Insulin-like Growth Factor-II/mannose-6-phosphate Receptor in Obesity and Type 2 Diabetes

Overview
Publisher Elsevier
Specialty Endocrinology
Date 2010 Jan 30
PMID 20110184
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The extracellular domain of the insulin-like growth factor II/mannose-6-phosphate receptor (IGF-II/M6P-R) is present in the circulation, but its relationship with plasma IGF-II is largely unknown. As IGF-II appears to be nutritionally regulated, we studied the impact of obesity, type 2 diabetes (T2D) and weight loss on circulating levels of IGF-II and its soluble receptor.

Methods: Twenty-three morbidly obese non-diabetic subjects were studied before and after gastric banding (GB), reducing their BMI from 59.3+/-1.8 to 52.7+/-1.6 kg/m(2). Lean controls (n=10, BMI 24.2+/-0.5 kg/m(2)), moderately obese controls (n=21, BMI 31.8+/-1.0 kg/m(2)) and obese T2D patients (n=20, BMI 32.3+/-0.8 kg/m(2)) were studied before and after a hyperinsulinaemic euglycaemic clamp.

Results: Morbidly obese subjects had elevated IGF-II/M6P-R and IGF-II levels, which both decreased following GB (IGF-II/M6P-R: from 0.97+/-0.038 to 0.87+/-0.030 nmol/l, P=0.001; IGF-II: from 134+/-7 to 125+/-6 nmol/l, P=0.01), as did fasting plasma glucose and insulin (P<0.05). However, the metabolic parameters correlated with neither IGF-II nor IGF-II/M6P-R. Obese diabetics had increased IGF-II/M6P-R as compared with lean and obese controls (0.82+/-0.031 vs. 0.70+/-0.033 vs. 0.74+/-0.026 nmol/l; P<0.03) and levels were unaffected by clamp. In the latter cohort, IGF-II/M6P-R but not IGF-II correlated with HbA1c, and fasting plasma C-peptide, insulin and glucose (0.34<r<0.45; P<0.05). In all subjects, BMI correlated with IGF-II/M6P-R (r=0.57; P<0.001) and IGF-II (r=0.39; P<0.005). IGF-II/M6P-R and IGF-II were not associated.

Conclusion: Serum IGF-II/M6P-R is up-regulated in morbid obesity, down-regulated by weight loss and elevated in moderately obese T2D. However, although plasma IGF-II was also reduced following GB, the two peptides were not statistically correlated. No acute effect of insulin was seen. These findings indicate that the IGF-II/M6P-R is nutritionally regulated, independently of IGF-II.

Citing Articles

Identification of genetic loci enriched in obese or lean T2D cases in the Korean population.

Lim E, Cho Y Genes Genomics. 2024; 47(2):235-243.

PMID: 39693004 DOI: 10.1007/s13258-024-01602-x.


The associations of IGF2, IGF2R and IGF2BP2 gene polymorphisms with gestational diabetes mellitus: A case-control study.

Li W, She L, Zhang M, Yang M, Zheng W, He H PLoS One. 2024; 19(5):e0298063.

PMID: 38701040 PMC: 11068199. DOI: 10.1371/journal.pone.0298063.


The Role of Obesity in Breast Cancer Pathogenesis.

Glassman I, Le N, Asif A, Goulding A, Alcantara C, Vu A Cells. 2023; 12(16).

PMID: 37626871 PMC: 10453206. DOI: 10.3390/cells12162061.


DHA Supplementation during Pregnancy in Women with Obesity Normalizes IGF2R Levels in the Placenta of Male Newborns.

Castro J, Umana-Perez A, Castano-Moreno E, Casanello P, Ronco A Int J Endocrinol. 2023; 2023:1515033.

PMID: 37408866 PMC: 10319466. DOI: 10.1155/2023/1515033.


Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients.

Birzniece V, Lam T, McLean M, Reddy N, Shahidipour H, Hayden A Endocr Connect. 2022; 11(4).

PMID: 35324467 PMC: 9066575. DOI: 10.1530/EC-21-0375.